White Papers

1. Connected Trial Execution: Why Integrating IRT, eCOA And Clinical Supply Matters More Than Ever 9/16/2026

   Many sponsors are still managing IRT, eCOA, and Clinical Supply for complex trials as separate functions, creating unnecessary risk. Explore what is needed to integrate these workflows safely.

2. Digital Twins: From Protocol Design to Predictive Study Execution 9/14/2026

   A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.

3. Accelerating Chronic Disease Clinical Study Reports With AI-Enabled Medical Writing And Expert Oversight 9/14/2026

   AI-enabled medical writing can cut clinical study report timelines by up to 70%, helping teams manage growing chronic disease trial documentation without sacrificing quality or oversight.

4. How Sponsors Are Responding To FDA's RTCT Request For Information 9/9/2026

   Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.

5. Developing Next-Generation Therapies For Breast Cancer Patients 9/8/2026

   Breast cancer trials span multiple subtypes and modalities. Learn how specialized oncology experience helps reduce enrollment risk and keep programs on track.

6. Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development 9/8/2026

   Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

7. Cross-Functional Best Practices For Signal Detection In Special Case Scenarios 9/7/2026

   When trial data fall short, real risk signals surface in inquiries, complaints, and reports. Learn how coordinated, cross-functional practices help catch risk earlier.

8. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

   This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

9. A Practical Guide To Harnessing The Value Of APAC For Global Trial Success 8/21/2026

   As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.

10. Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations 8/20/2026

    Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.